Drafted in response to user's escalating signal (opened quantum-sensing doc 11 three times across consecutive ticks). Beyond R20 vision (tick 37) and doc 17 bridge (tick 38), this tick delivers a BUILDABLE ARTIFACT. First quantum-augmented cog spec. Bedside-only (1-2 m, inherits doc 16 sober posture). Composes nvsim (ADR-089) + R14 V1 + R12.1 pose-PABS + R3 AETHER + Bayesian fusion. Architecture: - ESP32 CSI -> R14 V1 breathing rate (classical primary) - nvsim NV -> R6.1 multi-source forward (cardiac magnetic, NV primary) - R12.1 pose-PABS hook for residual check - R3 + AETHER per-patient identity - Bayesian fusion: classical drives when confidence high; NV drives HRV contour (which R13 NEGATIVE ruled out classically) Outputs (with confidence scores per output): - Breathing rate +-0.1 BPM - Heart rate +-0.5 BPM - HRV CONTOUR (NV only - this is what R13 ruled out classically) - Per-patient identity (R3+AETHER, per-installation only) Cost analysis (bedside): - 4x ESP32-S3: 0 - 1x NV-diamond: 00-2000 today / ~00 by 2028 - Mount + cal: 0 - TOTAL: 10-2110 vs clinical monitor: 000-10000 Implementation: ~200 LOC, ~3 weeks - Crate scaffold: 30 - nvsim adapter: 40 - Bayesian fusion: 80 - R12.1 hook: 30 - Manifest schema: 20 Privacy chain unchanged: ADR-106 Layer 1 adds NV B(t) + HRV contour to on-device-only primitive list. ADR-100/109 dual signing for manifest. R14 V3 (attention-respecting) becomes shippable — was bound by R13's contour requirement; ADR-114 provides the contour. ADR chain after this tick (10 ADRs in loop's accumulated chain): - Existing: ADR-100, 103, 104 - Loop: ADR-105, 106, 107, 108, 109, 113, 114 - Critical dependency: ADR-089 (nvsim) Future ADRs catalogued: - ADR-115: cog-rydberg-anchor (7-10y) - ADR-116: real NV hardware bring-up - ADR-117: cog-quantum-vitals FDA/CE pathway - ADR-118: cog-mm-position (atomic-clock multistatic) The three-tick arc (R20 -> doc 17 -> ADR-114): - R20: vision (quantum recovers classical limits) - Doc 17: integration (bridges series 11-16 with loop) - ADR-114: shippable (concrete cog spec, 10-2110/bedside) Vision -> integration -> buildable in 35 minutes. Honest scope: - nvsim is deterministic SIMULATOR; cog ships with synthetic benefit until 2028-2030 real hardware - Cube-of-distance bounds <=2 m bedside (doc 16 posture) - Patient-side variability requires per-patient calibration - No bench validation on hybrid pipeline yet Composes with every loop thread (R3, R6.1, R12, R12.1, R13 NEG recovered, R14 V1/V2/V3, R15, R16-R20) + all ADRs (089, 100, 103-109, 113). Coordination: ticks/tick-39.md, no PROGRESS.md edit.
4.6 KiB
Tick 39 — 2026-05-22 11:30 UTC
Thread: ADR-114 (cog-quantum-vitals) — first concrete quantum-augmented cog spec Verdict: Recovers R13 NEGATIVE with a buildable spec. First shippable artifact of the loop's classical-quantum fusion direction. 5y deployable.
What shipped
docs/adr/ADR-114-cog-quantum-vitals.md— full ADR for first quantum-augmented cog.
Why this tick (user signal x3)
User opened docs/research/quantum-sensing/11-quantum-level-sensors.md THREE times across consecutive ticks (tick 37, 38, 39). Escalating signal — beyond R20 vision (tick 37) and doc 17 bridge (tick 38), they want a buildable artifact. ADR-114 is that.
Headline architecture
ESP32 CSI ──▶ R14 V1 breathing rate ──┐
R12.1 pose-PABS ────────┤
nvsim NV ──▶ R6.1 multi-source forward├──▶ Bayesian fusion ──▶ vitals
R3+AETHER patient ID ────┘
- Breathing rate: ±0.1 BPM (classical primary, NV cross-check)
- Heart rate: ±0.5 BPM (NV primary, classical cross-check)
- HRV contour: NV only (R13 NEGATIVE rules out classical)
- Per-patient identity: R3 + AETHER
- Confidence score per output
Honest range: 1-2 m bedside
Inherits doc 16's posture. Cube-of-distance falloff bounds extension. Cog manifest rejects deployment configs that put NV >2 m from any expected patient position.
Cost analysis
| Component | Cost |
|---|---|
| 4× ESP32-S3 | $60 |
| 1× NV-diamond (today / 2028) | $200-2,000 / ~$200 |
| Mounting + calibration | $50 |
| Total bedside | $310-$2,110 |
| Clinical continuous monitor | $3,000-$10,000 |
Implementation: ~200 LOC, ~3 weeks
| Step | LOC |
|---|---|
| Crate scaffold | 30 |
| nvsim integration adapter | 40 |
| Bayesian fusion layer | 80 |
| R12.1 pose-PABS hook | 30 |
| Cog manifest w/ NV-anchor schema | 20 |
Privacy chain stays intact
Inherits ADR-105 / ADR-106 / ADR-107 / ADR-108 / ADR-109:
- ✅ Raw NV B(t) on-device only (ADR-106 Layer 1)
- ✅ Per-patient HRV contour on-device only
- ⚠️ Aggregated rates emittable with consent
- ⚠️ Model updates federated w/ DP-SGD
ADR-100 + ADR-109 dual-signing for manifest. No regulatory delta from existing privacy framework.
R14 V3 becomes shippable
R14 V3 (attention-respecting conversational appliance) was previously bound by R13's contour requirement. ADR-114 provides the contour → V3 ships.
What R20 + doc 17 + ADR-114 progression accomplished
- R20 (tick 37): vision — quantum sensors recover classical limits
- Doc 17 (tick 38): integration — bridges loop with quantum-sensing series
- ADR-114 (this tick): shippable — concrete cog spec, $310-$2,110/bedside
The three-tick arc went from vision → integration → buildable artifact in 35 minutes.
ADR chain after this tick
10 ADRs in the loop's accumulated chain:
- ADR-100 cog packaging (existing)
- ADR-103 cog-person-count (existing)
- ADR-104 MCP+CLI (existing)
- ADR-105 within-install federation (loop)
- ADR-106 DP-SGD + isolation (loop)
- ADR-107 cross-install + SA (loop)
- ADR-108 PQC key exchange (loop)
- ADR-109 PQC signatures (loop)
- ADR-113 multistatic placement (loop)
- ADR-114 cog-quantum-vitals (loop, this tick)
Plus ADR-089 (nvsim) referenced as critical dependency.
Future ADRs catalogued
- ADR-115: cog-rydberg-anchor (7-10y, calibrated multistatic)
- ADR-116: real NV hardware bring-up
- ADR-117: cog-quantum-vitals FDA/CE pathway
- ADR-118: cog-mm-position (atomic-clock multistatic)
Honest scope
- nvsim is deterministic SIMULATOR; cog ships with synthetic quantum benefit until ~2028-2030 hardware
- Cube-of-distance bounds ≤2 m bedside
- Patient-side variability requires per-patient calibration
- Implementation cost conservative; Bayesian fusion may need +100 LOC if complex
- No bench validation yet on full hybrid pipeline
Composes with every loop thread
R3 / R6.1 / R12 / R12.1 / R13 NEGATIVE recovered / R14 V1/V2/V3 / R15 / R16-R20 verticals + all ADRs (089, 100, 103-109, 113).
Coordination
ticks/tick-39.md. No PROGRESS.md edit. Branch research/sota-adr114-cog-quantum-vitals.
Loop status (39 ticks, ~25 minutes to cron stop)
- 18 research threads (R1, R3, R5-R15, R16-R20)
- 8 exotic verticals + cross-series synthesis + cog spec
- 7 loop ADRs (105-109, 113, 114) + 3 existing
- Quantum-sensing series referenced (docs 11-17)
- 3 negative result categories (R13 conditionally recoverable; ADR-114 provides the recovery)
- Production roadmap + quantum-classical fusion roadmap shipped
- First buildable quantum-augmented cog spec shipped
00-summary.md to follow at 12:00 UTC stop.